1-20312836-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001039500.3(VWA5B1):c.140G>A(p.Gly47Asp) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000652 in 1,548,446 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001039500.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWA5B1 | NM_001039500.3 | c.140G>A | p.Gly47Asp | missense_variant, splice_region_variant | 3/22 | ENST00000289815.13 | NP_001034589.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWA5B1 | ENST00000289815.13 | c.140G>A | p.Gly47Asp | missense_variant, splice_region_variant | 3/22 | 5 | NM_001039500.3 | ENSP00000289815 | A2 | |
ENST00000444923.1 | n.85+10267C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000261 AC: 4AN: 153372Hom.: 0 AF XY: 0.0000246 AC XY: 2AN XY: 81290
GnomAD4 exome AF: 0.0000688 AC: 96AN: 1396202Hom.: 0 Cov.: 30 AF XY: 0.0000610 AC XY: 42AN XY: 688048
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2022 | The c.140G>A (p.G47D) alteration is located in exon 3 (coding exon 2) of the VWA5B1 gene. This alteration results from a G to A substitution at nucleotide position 140, causing the glycine (G) at amino acid position 47 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at